Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats

Endocrinology

Volumn 155, Issue 4, 2014, Pages 1235-1246

  Wang, Ya Yu ^a,b,c   Lin, Shih Yi ^a,c   Chuang, Yu Han ^a   Sheu, Wayne Huey Herng ^a,c   Tung, Kwong Chung ^b   Chen, Chun Jung ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; GLUCOSE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPRANOLOL; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SHAM PROCEDURE; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN ISCHEMIA; CATECHOLAMINES; CELL NUCLEUS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIVER; MALE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897870274     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1593     Document Type: Article

References (47)

1. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432. (Pubitemid 32954818)
2. Gray CS, Hildreth AJ, Alberti GK., O'Connell JE on behalf of the GIST Collaboration. Poststroke hyperglycemia: natural history and immediate management. Stroke. 2004;35:122-126. (Pubitemid 38057604)
3. McCormick MT, Muir KW, Gray CS, Walters MR. Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke. 2008;39:2177-2185.
4. Kent TA, Soukup VM, Fabian RH. Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse. Stroke. 2001;32:2318-2327. (Pubitemid 32954803)
5. Bruno A, Kent TA, Coull BM, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008;39:384-389. (Pubitemid 351619460)
6. Cherrington AD, Edgerton D, Sindelar DK. The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia. 1998;41:987-996. (Pubitemid 28394402)
7. Klover PJ, Mooney RA. Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol. 2004;36:753-758. (Pubitemid 38299389)
8. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42:987-1000. (Pubitemid 43112663)
9. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130-1139. (Pubitemid 44115261)
10. Rizza RA. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes. 2010;59:2697-2707.
11. Diehl AM. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8:619-638, x. (Pubitemid 39141146)
12. Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab. 2008;19:371-379.
13. Nakatani Y, Kaneto H, Kawamori D, et al. Modulation of JNK pathway in liver affects insulin resistance status. J Biol Chem. 2004;279:45803-45809. (Pubitemid 39491572)
14. Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med. 2005;11:183-190. (Pubitemid 40321354)
15. Karin M, Yamamoto Y, Wang QM. The IKK NFκB system: a treasure trove for drug development. Nat Rev Drug Discov. 2004;3:17-26. (Pubitemid 38088695)
16. Xu J, Kim HT, Ma Y, et al. Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor-α. Endocrinology. 2008;149:2369-2382. (Pubitemid 351574510)
17. Gauglitz GG, Halder S, Boehning DF, et al. Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stress. Shock. 2010;33:299-305.
18. Jiang S, Messina JL. Role of inhibitory κB kinase and c-Jun NH2-terminal kinase in the development of hepatic insulin resistance in critical illness diabetes. Am J Physiol Gastrointest Liver Physiol. 2011;301:G454-G463.
19. Wang YY, Lin SY, Chuang YH, Chen CJ, Tung KC, Sheu WH. Adipose proinflmmatory cytokine expression through sympathetic system is associated with hyperglycemia and insulin resistance in a rat ischemic stroke model. Am J Physiol Endocrinol Metab. 2011;300:E155-E163.
20. Wang YY, Chen CJ, Lin SY, Chuang YH, Sheu WH, Tung KC. Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia. Mol Cell Endocrinol. 2013;367:50-56.
21. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006;26:654-665.
22. Ottani A, Giuliani D, Mioni C, et al. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J Cereb Blood Flow Metab. 2009;29:512-523.
23. O'Neill PA, Davies I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke. 1991;22:842-847.
24. Cheung RT, Hachinski VC, Cechetto DF. Cardiovascular response to stress after middle cerebral artery occlusion in rats. Brain Res. 1997;747:181-188. (Pubitemid 27077391)
25. Swain MG. I. Stress and hepatic inflammation. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1135-G1138.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
27. Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-α. Am J Physiol Endocrinol Metab. 2005;288:E493-E501. (Pubitemid 40250543)
28. Wullaert A, van Loo G, Heyninck K, Beyaert R. Hepatic tumor necrosis factor signaling and nuclear factor-κB: effects on liver homeostasis and beyond. Endocr Rev. 2007;28:365-386. (Pubitemid 46984825)
29. Jitrapakdee S. Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. Int J Biochem Cell Biol 2012;44:33-45.
30. Tripathy D, Almgren P, Tuomi T, Groop L. Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care. 2004;27:2204-2210. (Pubitemid 39167186)
31. Catania A, Lonati C, Sordi A, Gatti S. Detrimental consequences of brain injury on peripheral cells. Brain Behav Immun. 2009;23:877-884.
32. Campbell SJ, Perry VH, Pitossi FJ, et al. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol. 2005;166:1487-1497. (Pubitemid 40586518)
33. Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012;143:307-320.
34. Aninat C, Seguin P, Descheemaeker PN, Morel F, Malledant Y, Guillouzo A. Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med. 2008;36:848-854.
35. Tan KS, Nackley AG, Satterfield K, Maixner W, Diatchenko L, Flood PM. β2 Adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms. Cell Signal. 2007;19:251-260. (Pubitemid 46017083)
36. Yin F, Wang YY, Du JH, et al. Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol. 2006;40:384-393. (Pubitemid 43277840)
37. Wang J, Li J, Sheng X, et al. β-Adrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells. J Neuroimmunol. 2010;223:77-83.
38. Keeton TK, Biediger AM. Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:47-55.
39. Rojas FA, Hirata AE, Saad MJ. Regulation of insulin receptor substrate-2 tyrosine phosphorylation in animal models of insulin resistance. Endocrine. 2003;21:115-122. (Pubitemid 36936350)
40. Dziedzic T, Pera J, Zur-Wyrozumska K, Klimkowicz-Mrowiec A, Szczudlik A, Slowik A. β-Blockers use and risk of hyperglycemia in acute stroke patients. Atherosclerosis. 2012;223:209-211.
41. De Raedt S, Haentjens P, De Smedt A, et al. Pre-stroke use of beta-blockers does not affect ischaemic stroke severity and outcome. Eur J Neurol 2012;19:234-240.
42. Lang CH. Sepsis-induced insulin resistance in rats is mediated by a β-adrenergic mechanism. Am J Physiol. 1992;263:E703-E711.
43. Brooks NC, Song J, Boehning D, et al. Propranolol improves impaired insulin hepatic phosphatidylinositol 3-kinase/akt signaling after burn injury. Mol Med. 2012;18:707-711.
44. Nawano M, Oku A, Ueta K, et al. Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab. 2000;278:E535-E543. (Pubitemid 30149399)
45. Shao J, Qiao L, Janssen RC, Pagliassotti M, Friedman JE. Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes. 2005;54:976-984. (Pubitemid 40446311)
46. Ma Y, Wang P, Kuebler JF, Chaudry IH, Messina JL. Hemorrhage induces the rapid development of hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2003;284:G107-G115. (Pubitemid 36076255)
47. Tsuchiya K, Accili D. Liver sinusoidal endothelial cells link hyperinsulinemia to hepatic insulin resistance. Diabetes. 2013;62:1478-1489.